To synthesize evidence on whether ADHD is associated with higher all-cause and cause-specific mortality than no ADHD, and whether ADHD medication use is associated with lower all-cause mortality among people with ADHD.
Approach:
Design: Systematic review and meta-analysis reported in accordance with PRISMA.
Search: On July 8, 2025, researchers searched PubMed, Web of Science, PsycINFO, EMBASE, MEDLINE, and CINAHL without language or time restrictions, and checked reference lists of eligible studies.
Scope: The review aimed to include evidence from 1990 through 2019 and considered ADHD identified by diagnosis, trait measures, or self-identification.
Interpretation:
The provided context describes the review rationale, objectives, and search methods but does not report results or pooled estimates.
Limitations:
The supplied article context ends during the methods description and provides no study-selection details, results, or risk-of-bias assessment.
Conclusion:
The review was designed to assess all-cause and cause-specific mortality associated with ADHD and the relationship between ADHD medication use and all-cause mortality.
